Beyhan Ataseven

4.1k total citations
124 papers, 2.3k citations indexed

About

Beyhan Ataseven is a scholar working on Reproductive Medicine, Oncology and Cancer Research. According to data from OpenAlex, Beyhan Ataseven has authored 124 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Reproductive Medicine, 54 papers in Oncology and 42 papers in Cancer Research. Recurrent topics in Beyhan Ataseven's work include Ovarian cancer diagnosis and treatment (54 papers), Endometrial and Cervical Cancer Treatments (29 papers) and Breast Cancer Treatment Studies (29 papers). Beyhan Ataseven is often cited by papers focused on Ovarian cancer diagnosis and treatment (54 papers), Endometrial and Cervical Cancer Treatments (29 papers) and Breast Cancer Treatment Studies (29 papers). Beyhan Ataseven collaborates with scholars based in Germany, Austria and Italy. Beyhan Ataseven's co-authors include Philipp Harter, Andreas du Bois, Florian Heitz, Alexander Traut, Sonia Prader, Gϋnter von Minckwitz, Christoph Grimm, Sibylle Loibl, Sebastian Heikaus and Carsten Denkert and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Beyhan Ataseven

110 papers receiving 2.3k citations

Peers

Countries citing papers authored by Beyhan Ataseven

Since Specialization

Citations

This map shows the geographic impact of Beyhan Ataseven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beyhan Ataseven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beyhan Ataseven more than expected).

Fields of papers citing papers by Beyhan Ataseven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beyhan Ataseven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beyhan Ataseven. The network helps show where Beyhan Ataseven may publish in the future.

Co-authorship network of co-authors of Beyhan Ataseven

This figure shows the co-authorship network connecting the top 25 collaborators of Beyhan Ataseven. A scholar is included among the top collaborators of Beyhan Ataseven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beyhan Ataseven. Beyhan Ataseven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both 2024 ·International Journal of Gynecological Cancer ·Eric Rios‐Doria, Nadeem R. Abu‐Rustum, Gretchen Glaser, (unknown), Ane Gerda Zahl Eriksson, (unknown), Pamela T. Soliman, Beyhan Ataseven, Kaled M. Alektiar, Dmitriy Zamarin, Mario M. Leitão, Jennifer J. Mueller	0
2	Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer 2024 ·Geburtshilfe und Frauenheilkunde ·Clemens Tempfer, Tanja Fehm, Dirk Vordermark, (unknown), Matthias W. Beckmann, Dominik Denschlag, Sara Y. Brucker, Markus Wallwiener, Michael Eichbaum, Beyhan Ataseven, Peter Hillemanns, (unknown)	1
3	Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial 2024 ·Gynecologic Oncology ·Mansoor R. Mirza, Line Bjørge, Frederik Marmé, René dePont Christensen, Marta Gil-Martín, Annika Auranen, Beyhan Ataseven, María Jesús Rubio, (unknown), A.A. Luczak, Ingo B. Runnebaum, Andrés Redondo, Kristina Lindemann, Fabian Trillsch, M.P. Barretina Ginesta, Henrik Roed, J.E. Kurtz, (unknown), Gitte‐Bettina Nyvang, (unknown)	3
4	750P PFS2 and adjustment of overall survival (OS) for subsequent anticancer therapy in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab plus chemotherapy or chemotherapy alone in the ENGOT-EN3-NSGO/GOG-3031/RUBY trial 2023 ·Annals of Oncology ·Brian M. Slomovitz, (unknown), Robert L. Coleman, Lucy Gilbert, Matthew A. Powell, David Cibula, Sharad Ghamande, (unknown), Alberto A. Mendivil, Beyhan Ataseven, Destin Black, (unknown), Caroline C. Billingsley, Lyndsay Willmott, Carolyn K. McCourt, Iwona Podzielinski, (unknown), (unknown), Thomas J. Herzog, Mansoor Raza Mirza	2
5	Zielgerichtete Therapien beim rezidivierten Endometriumkarzinom 2: Moderne Ansätze 2023 ·(unknown), Beyhan Ataseven	0
6	2022-RA-778-ESGO Rare gynecological cancers in a gynecologic cancer center: 11-year experience of KEM 2022 ·International Journal of Gynecological Cancer ·(unknown), Beyhan Ataseven, Florian Heitz, (unknown), (unknown), (unknown), (unknown), (unknown), Alexander Traut, Andreas du Bois, Philipp Harter	1
7	Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study 2022 ·International Journal of Gynecological Cancer ·(unknown), Nicolò Bizzarri, Robert Fruscio, Anna Myriam Perrone, Alexander Traut, Andreas du Bois, Andrea Rosati, (unknown), Pierandrea De Iaco, Beyhan Ataseven, (unknown), (unknown), Marco Tesei, Florian Heitz, Maria Teresa Perri, Nicole Concin, Francesco Fanfani, Giovanni Scambia, Anna Fagotti, Philipp Harter	2
8	Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients 2022 ·International Journal of Gynecological Cancer ·(unknown), Beyhan Ataseven, Chiara Cassani, (unknown), (unknown), Marco D’Indinosante, Serena Cappuccio, Kerstin Rhiem, Eric Hahnen, Emanuela Lucci‐Cordisco, Eloisa Arbustini, Philipp Harter, Angelo Minucci, Giovanni Scambia, Anna Fagotti	3
9	Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire 2022 ·Genes ·N Herold, Martin Hellmich, (unknown), Beyhan Ataseven, (unknown), Barbara Wappenschmidt, Rita K. Schmutzler, Kerstin Rhiem	6
10	Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study 2022 ·The Breast ·Joseph Gligorov, Xavier Pivot, Beyhan Ataseven, Michelino De Laurentiis, Kyung Hae Jung, Alexey Manikhas, Hamdy A. Azim, Kushagra Gupta, (unknown), (unknown), Nadia Tosti, Eleonora Restuccia	8
11	Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer—Impact for Diagnosis and Treatment Monitoring 2021 ·Cancers ·Elena Ioana Braicu, Andreas du Bois, Jalid Sehouli, Julia Beck, Sonia Prader, Hagen Kulbe, B. Eiben, Philipp Harter, Alexander Traut, Klaus Pietzner, (unknown), Beyhan Ataseven, Radoslav Chekerov, Christoph Keck, Thomas W. Winkler, Sebastian Heikaus, (unknown), Ekkehard Schütz, Florian Heitz	8
12	European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma 2021 ·International Journal of Gynecological Cancer ·Nicole Concin, François Planchamp, Nadeem R. Abu‐Rustum, Beyhan Ataseven, David Cibula, Anna Fagotti, Christina Fotopoulou, Paweł Knapp, Christian Marth, Philippe Morice, Denis Querleu, Jalid Sehouli, Artem Stepanyan, Çağatay Taşkıran, Ignace Vergote, Pauline Wimberger, Ignacio Zapardiel, Jan Persson	20
13	Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice 2021 ·Cancers ·(unknown), (unknown), (unknown), Elisabeth Breit, Beyhan Ataseven, Alexander Traut, (unknown), (unknown), (unknown), (unknown), Mattea Reinisch	9
14	Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer 2018 ·Gynecologic Oncology ·Sonia Prader, (unknown), Andreas du Bois, Florian Heitz, Stephanie Schneider, Beyhan Ataseven, Mareike Bommert, (unknown), Sebastian Heikaus, (unknown), Pier Francesco Alesina, Alexander Traut, Philipp Harter	27
15	Updated Survival Analysis after a Median Follow-up of 12 Years of an Anthracycline-Containing Adjuvant Prospective Multicentre, Randomised Phase III Trial on Dose-Dense Chemotherapy in Primary Node-Positive, High-Risk Breast Cancer Patients 2018 ·Breast Care ·Mattea Reinisch, Oleg Gluz, Beyhan Ataseven, Jens‐Uwe Blohmer, (unknown), (unknown), A. Kohls, (unknown), (unknown), (unknown), (unknown), Alexander Traut, Sherko Kümmel	2
16	Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis 2018 ·Human Mutation ·Konstantin Weber‐Lassalle, Philipp Harter, Jan Hauke, Corinna Ernst, Stefan Kommoss, Frederik Marmé, Nana Weber‐Lassalle, Katharina Prieske, Dimo Dietrich, Julika Borde, Esther Pohl‐Rescigno, Alexander Reuß, Beyhan Ataseven, Christoph Engel, Julia Stingl, Rita K. Schmutzler, Eric Hahnen	17
17	Adjuvant subcutaneous trastuzumab for HER2-positive early breast cancer: Phase III SafeHer study subgroup analyses of body weights, active medical conditions, safety and tolerability 2016 ·Annals of Oncology ·Kyung Hae Jung, Beyhan Ataseven, Mark Verrill, Xavier Pivot, Michelino De Laurentiis, N. Al-Sakaff, Sabine Lauer, Mona Shing, Joseph Gligorov, Hamdy A. Azim	1
18	PTK7 expression in triple-negative breast cancer. 2013 ·PubMed ·Beyhan Ataseven, (unknown), Ronald Kates, (unknown), Pjotr Knyazev, B. Högel, (unknown), W. Eiermann, Nadia Harbeck	32
19	Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer 2012 ·PLoS ONE ·Antonia Wenners, Keyur Mehta, Sibylle Loibl, Hye‐Rim Park, (unknown), Norbert Arnold, (unknown), Jörg Weimer, Beyhan Ataseven, Silvia Darb‐Esfahani, Christian Schem, Christoph Mundhenke, F Khandan, Christoph Thomssen, W. Jonat, (unknown), (unknown), Carsten Denkert, M. Bauer	44
20	Vaginale Hysterektomie und beidseitige Adnexektomie in interdisziplinärem Konzept bei Frau zu Mann – Transsexualismus 2011 ·Handchirurgie · Mikrochirurgie · Plastische Chirurgie ·Claudia Kaiser, (unknown), Beyhan Ataseven, (unknown), J. Schaff, W. Eiermann	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact